MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.
- DOI
- 10.1089/cbr.2019.2858
- Published
- 2019 Nov
- Container
- Cancer biotherapy & radiopharmaceuticals
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1089/cbr.2019.2858,
title = {MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.},
author = {Xu X and Jiang X and Chen L and Zhao Y and Huang Z and Zhou H and Shi M},
year = {2019},
journal = {Cancer biotherapy \& radiopharmaceuticals},
doi = {10.1089/cbr.2019.2858},
url = {https://doi.org/10.1089/cbr.2019.2858}
}RIS
TY - JOUR TI - MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells. AU - Xu X AU - Jiang X AU - Chen L AU - Zhao Y AU - Huang Z AU - Zhou H AU - Shi M PY - 2019 JO - Cancer biotherapy & radiopharmaceuticals DO - 10.1089/cbr.2019.2858 UR - https://doi.org/10.1089/cbr.2019.2858 ER -
APA
X, X., X, J., L, C., Y, Z., Z, H., H, Z., & M, S. (2019). MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.. Cancer biotherapy & radiopharmaceuticals. https://doi.org/10.1089/cbr.2019.2858
Source records
- pubmed · retrieved 2026-09-25T00:30:04.397Z